Impact of study design on vaccine effectiveness estimates of 2 mRNA COVID-19 vaccine doses in patients with stage 5 chronic kidney disease

Thumbnail image

Download files

DOI

https://doi.org/10.1016/j.kint.2023.01.009

Language of the publication
English
Date
2023-04
Type
Article
Author(s)
  • Naylor, Kyla L.
  • McArthur, Eric
  • Dixon, Stephanie N.
  • Kwong, Jeffrey C.
  • Thomas, Doneal
  • Balamchi, Shabnam
  • Blake, Peter G.
  • Garg, Amit X.
  • Atiquzzaman, Mohammad
  • Hladunewich, Michelle A.
  • Levin, Adeera
  • Yeung, Angie
  • Oliver, Matthew J.
Publisher
International Society of Nephrology

Subject

  • Health,
  • Coronavirus diseases,
  • Immunization

Rights

Pagination

791-797

Identifiers

PubMed ID
36731610
ISSN
1523-1755

Article

Journal title
Kidney International
Journal volume
103
Journal issue
4

Sponsors

COVID-19 Immunity Task Force (grant 2122-HQ-000071)

Download(s)

URI

Collection(s)

Communicable diseases

Full item page

Full item page

Page details

Date modified: